SuperworthSarepta Therapeutics shares outstanding SRPT
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 105.4M
- On a year earlier
- −1.1%
- fewer shares
Sarepta Therapeutics had 105.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.1% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 132.6M | +28% |
| FY2023 | 103.6M | +18% |
| FY2022 | 87.8M | +2% |
| FY2021 | 85.9M | +9% |
| FY2020 | 78.9M | +6% |
| FY2019 | 74.6M | +9% |
| FY2018 | 68.7M | +8% |
| FY2017 | 63.7M | +17% |
| FY2016 | 54.6M | +22% |
| FY2015 | 44.9M | +9% |
| FY2014 | 41.3M | +10% |
| FY2013 | 37.6M | +43% |
| FY2012 | 26.3M | +16% |
| FY2011 | 22.6M | +21% |
| FY2010 | 18.7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 105.4M | −1% | |
| Q1 FY26 | 121.9M | +25% | |
| Q3 FY25 | 100.2M | −0% | |
| Q2 FY25 | 106.6M | +8% | |
| Q1 FY25 | 97.4M | −2% | |
| Q4 FY24 | 132.6M | +28% | |
| Q3 FY24 | 100.4M | +13% | |
| Q2 FY24 | 99.1M | +12% | |
| Q1 FY24 | 99.1M | +12% | |
| Q4 FY23 | 103.6M | +18% | |
| Q3 FY23 | 88.9M | +1% | |
| Q2 FY23 | 88.7M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Sarepta Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.